Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVO) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Evotec SE (EVO) over the last 9 years, with Q3 2025 value amounting to $207.7 million.

  • Evotec SE's Shares Outstanding (Weighted Average) rose 664.39% to $207.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.7 million, marking a year-over-year increase of 664.39%. This contributed to the annual value of $189.5 million for FY2024, which is 47.03% down from last year.
  • As of Q3 2025, Evotec SE's Shares Outstanding (Weighted Average) stood at $207.7 million, which was up 664.39% from $189.5 million recorded in Q4 2024.
  • Over the past 5 years, Evotec SE's Shares Outstanding (Weighted Average) peaked at $207.7 million during Q3 2025, and registered a low of $1768.9 during Q3 2021.
  • For the 5-year period, Evotec SE's Shares Outstanding (Weighted Average) averaged around $164.4 million, with its median value being $190.4 million (2023).
  • Examining YoY changes over the last 5 years, Evotec SE's Shares Outstanding (Weighted Average) showed a top increase of 1007178768.4% in 2022 and a maximum decrease of 531.2% in 2022.
  • Evotec SE's Shares Outstanding (Weighted Average) (Quarter) stood at $190.4 million in 2021, then decreased by 5.31% to $180.3 million in 2022, then grew by 5.6% to $190.4 million in 2023, then dropped by 0.47% to $189.5 million in 2024, then grew by 9.63% to $207.7 million in 2025.
  • Its last three reported values are $207.7 million in Q3 2025, $189.5 million for Q4 2024, and $194.8 million during Q3 2024.